Eun-Gyoung. Hong, et.al., Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling., American journal of physiology. Endocrinology and metabolism, 2007, 293

http://rdf.ncbi.nlm.nih.gov/pubmed/17911348

Eun-Gyoung. Hong, et.al., Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling., American journal of physiology. Endocrinology and metabolism, 2007, 293

pubmed

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• hyperglycemia_Ins2<Akita>/?
  http://metadb.riken.jp/0001559IC57BL6NSlcIns2AkitaIns2Akita
• insulin resistance_Ins2<Akita>/?
  http://metadb.riken.jp/0005331IC57BL6NSlcIns2AkitaIns2Akita
• decreased liver triglyceride level_Ins2<Akita>/?
  http://metadb.riken.jp/0009356IC57BL6NSlcIns2AkitaIns2Akita
• increased energy expenditure_Ins2<Akita>/?
  http://metadb.riken.jp/0004889IC57BL6NSlcIns2AkitaIns2Akita
• decreased adipocyte glucose uptake_Ins2<Akita>/?
  http://metadb.riken.jp/0030017IC57BL6NSlcIns2AkitaIns2Akita
• decreased muscle cell glucose uptake_Ins2<Akita>/?
  http://metadb.riken.jp/0030022IC57BL6NSlcIns2AkitaIns2Akita
• abnormal cardiac muscle contractility_Ins2<Akita>/?
  http://metadb.riken.jp/0002972IC57BL6NSlcIns2AkitaIns2Akita
• abnormal heart left ventricle morphology_Ins2<Akita>/?
  http://metadb.riken.jp/0003921IC57BL6NSlcIns2AkitaIns2Akita
• increased carbon dioxide production_Ins2<Akita>/?
  http://metadb.riken.jp/0008963IC57BL6NSlcIns2AkitaIns2Akita
• abnormal glucose homeostasis_Ins2<Akita>/?
  http://metadb.riken.jp/0002078IC57BL6NSlcIns2AkitaIns2Akita
• decreased circulating triglyceride level_Ins2<Akita>/?
  http://metadb.riken.jp/0002644IC57BL6NSlcIns2AkitaIns2Akita
• increased oxygen consumption_Ins2<Akita>/?
  http://metadb.riken.jp/0005289IC57BL6NSlcIns2AkitaIns2Akita
• heart left ventricle hypertrophy_Ins2<Akita>/?
  http://metadb.riken.jp/0002625IC57BL6NSlcIns2AkitaIns2Akita
• decreased body weight_Ins2<Akita>/?
  http://metadb.riken.jp/0001262IC57BL6NSlcIns2AkitaIns2Akita
• decreased circulating insulin level_Ins2<Akita>/?
  http://metadb.riken.jp/0002727IC57BL6NSlcIns2AkitaIns2Akita
• decreased respiratory quotient_Ins2<Akita>/?
  http://metadb.riken.jp/0010379IC57BL6NSlcIns2AkitaIns2Akita
• increased adipocyte glucose uptake_Ins2<Akita>/?
  http://metadb.riken.jp/0030016IC57BL6NSlcIns2AkitaIns2Akita
• decreased body fat mass_Ins2<Akita>/?
  http://metadb.riken.jp/0014143IC57BL6NSlcIns2AkitaIns2Akita
• increased food intake_Ins2<Akita>/?
  http://metadb.riken.jp/0011939IC57BL6NSlcIns2AkitaIns2Akita
• decreased triglyceride level_Ins2<Akita>/?
  http://metadb.riken.jp/0005318IC57BL6NSlcIns2AkitaIns2Akita
• hypoactivity_Ins2<Akita>/?
  http://metadb.riken.jp/0001402IC57BL6NSlcIns2AkitaIns2Akita
• abnormal heart morphology_Ins2<Akita>/?
  http://metadb.riken.jp/0000266IC57BL6NSlcIns2AkitaIns2Akita
• thick interventricular septum_Ins2<Akita>/?
  http://metadb.riken.jp/0010724IC57BL6NSlcIns2AkitaIns2Akita

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• hypoactivity in RBRC02661
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1011690
• abnormal heart morphology in RBRC02661
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004814
• decreased circulating triglyceride level in RBRC02661
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004817
• heart left ventricle hypertrophy in RBRC02659
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1015882
• abnormal cardiac muscle contractility in RBRC02661
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004819
• thick interventricular septum in RBRC02659
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1015897
• decreased circulating insulin level in RBRC02659
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1015884
• increased carbon dioxide production in RBRC02661
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004834
• abnormal muscle cell glucose uptake in RBRC02659
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1015887
• thick interventricular septum in RBRC02661
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004837
• increased oxygen consumption in RBRC02661
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004826
• increased energy expenditure in RBRC02661
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004823
• abnormal muscle cell glucose uptake in RBRC02661
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004821
• insulin resistance in RBRC02661
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004829
• heart left ventricle hypertrophy in RBRC02661
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004816
• increased carbon dioxide production in RBRC02659
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1015894
• decreased body fat mass in RBRC02661
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1018754
• increased energy expenditure in RBRC02659
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1015889
• decreased respiratory quotient in RBRC02659
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1015896
• decreased adipocyte glucose uptake in RBRC02661
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1018756
• abnormal heart left ventricle morphology in RBRC02661
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004820
• abnormal adipocyte glucose uptake in RBRC02661
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004822
• abnormal glucose homeostasis in RBRC02661
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004815
• decreased liver triglyceride level in RBRC02659
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1015895
• abnormal adipose tissue amount in RBRC02659
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1015893
• decreased liver triglyceride level in RBRC02661
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004835
• abnormal heart morphology in RBRC02659
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1015880
• abnormal adipose tissue amount in RBRC02661
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004830
• decreased circulating triglyceride level in RBRC02659
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1015883
• abnormal cardiac muscle contractility in RBRC02659
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1015885
• decreased circulating insulin level in RBRC02661
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1011701
• decreased triglyceride level in RBRC02661
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004827
• decreased muscle cell glucose uptake in RBRC02661
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1018757
• insulin resistance in RBRC02659
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1015892
• increased oxygen consumption in RBRC02659
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1015890
• abnormal heart left ventricle morphology in RBRC02659
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1015886
• decreased respiratory quotient in RBRC02661
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004836
• hypoactivity in RBRC02659
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1015881
• decreased triglyceride level in RBRC02659
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1015891
• abnormal adipocyte glucose uptake in RBRC02659
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1015888
• increased adipocyte glucose uptake in RBRC02661
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1018755